Covid vaccine equity remains out of reach, as wealthy nations drag their feet on donations, and vaccine stocks pass their use-by dates.
By Lucien Hordijk and Priti Patnaik | 23 May 2022
Though Brussels was largely successful in buying billions of covid-19 vaccine doses for an entire continent, circumventing nationalist policies and bidding wars between member states, it did not have a playbook for donating the hundreds of millions of surplus jabs it had triumphantly over-ordered.
Read the full article on BMJ.
